Financials data is unavailable for this security.
Cash flow in CNYView more
In 2023, cash reserves at SinoMab BioScience Ltd fell by 139.22m. Cash Flow from Financing totalled 82.27m or 6,026.89% of revenues. In addition the company used 133.85m for operations while cash used for investing totalled 96.92m.
Cash flow per share | -- |
---|---|
Price/Cash flow per share | -- |
Book value per share | 0.2792 |
---|---|
Tangible book value per share | 0.278 |
More ▼
Balance sheet in CNYView more
Current ratio | 1.31 |
---|---|
Quick ratio | -- |
Total debt/total equity | 1.73 |
---|---|
Total debt/total capital | 0.6339 |
More ▼